1. Brew BK, Gibson PG, Collison A, Karmaus W, et al.
   Prenatal wildfire smoke exposure and adverse neonatal outcomes in a high-risk cohort of pregnant women with asthma.
   Am J Obstet Gynecol 2026.
   


2. Rolnik DL, Tan MY, Syngelaki A, Wright D, et al.
   Combined Impact of First-Trimester Risk and Aspirin Adherence on Preterm Pre-eclampsia Prevention.
   Am J Obstet Gynecol 2026.
   


3. Dall'Asta A, Stampalija T, Wolf H, Lees C, et al.
   Identification of preterm growth restricted fetuses requiring delivery within 7 days.
   Am J Obstet Gynecol 2026.
   


4. Hulse WN, Bahr TM, Ostrander B, Winter S, et al.
   Iron Deficiency Screening with Reticulocyte-Hemoglobin Content and 2-Year Neurodevelopmental Outcomes in Extremely Low Birth Weight Infants.
   Am J Perinatol 2026.
   


5. Quinn M, Katheria AC, Profit J, Lee H, et al.
   Deferred cord clamping and weight difference for very preterm infants.
   Am J Perinatol 2026.
   


6. Flenady VJ, Wojcieszek AM, Astell C, Dahlstrom JE, et al.
   Classifying Stillbirths and Neonatal Deaths to Inform Prevention Strategies.
   Clin Perinatol 2026;53:13-28.
   


7. Gibier C, Le Ray I, Kuhn P, Jacquin C, et al.
   Nasal cutaneous impact of non-invasive respiratory support for extremely preterm neonates: a descriptive, prospective, multicenter study.
   Eur J Pediatr 2026;185:136.
   


8. Marzban A, Karami Dehkordi P.
   Surfactant therapy in neonatal care: advances, challenges, and practical considerations.
   Eur J Pediatr 2026;185.
   


9. Lindel F, Steinkasserer L, Dutemeyer V, Rahn A, et al.
   Fighting preterm birth with the scalpel: lessons from a decade of total cervical occlusion.
   J Perinat Med 2026.
   


10. Ramachandra R, Arunamata A, Moy A, Tracy MC, et al.
    Results of a pulmonary hypertension screening program for premature infants with bronchopulmonary dysplasia.
    J Perinatol 2026.
    


11. Zierk AW, Gibbs KA, Nelin TD, Huber M, et al.
    Association between the respiratory severity score and extubation success in severe bronchopulmonary dysplasia.
    J Perinatol 2026;46:188-192.
    


12. Collaco JM, Eldredge LC, McGrath-Morrow SA.
    Long-term pulmonary outcomes in BPD throughout the life-course.
    J Perinatol 2026;46:127-135.
    


13. Goffinon E, Badr DA, Lefevre N, Vuckovic A, et al.
    Rising rates of non-invasive ventilation and bronchopulmonary dysplasia: A propensity score-matched analysis.
    J Perinatol 2026;46:224-232.
    


14. Darwish N, Donnelly A, Erkinger J, Zhang S, et al.
    A non-invasive diagnostic tool for the assessment of optimal positive-end expiratory pressure (PEEP(OPT)) in infants receiving prolonged invasive ventilation.
    J Perinatol 2026.
    


15. Adiletta N, Denslow A, Martinez R, Walti B, et al.
    Finding treasure in the journey: a single center quality improvement bundle to reduce bronchopulmonary dysplasia.
    J Perinatol 2026;46:299-307.
    


16. Foote HP, Sun M, Goldstein BA, Hill KD, et al.
    Predicting pulmonary hypertension in infants with bronchopulmonary dysplasia.
    J Perinatol 2026.
    


17. Farrell K, DeMauro SB, Gibbs K, Morris H, et al.
    Health-related quality of life among families of children with severe bronchopulmonary dysplasia.
    J Perinatol 2026;46:200-205.
    


18. Flannery DD, Green MB, Mehler K.
    Bacterial and fungal infections in infants born before 24 weeks' gestation: a review.
    J Perinatol 2026.
    


19. Raghuveer TS, Zackula RE, Lakhotia R, Binder SA, et al.
    Systemic steroids and bronchopulmonary dysplasia: a systematic review and meta-analysis.
    J Perinatol 2026;46:144-154.
    


20. Kielt MJ, Nelin TD, Abman SH, Nelin LD, et al.
    Toward precision for bronchopulmonary dysplasia: Moving past current definitions.
    J Perinatol 2026;46:308-314.
    


21. Mahaney KB, Cheetham-West A, Cui X, Liu J, et al.
    Wide variation in death rates and post-hemorrhagic hydrocephalus (PHH) treatment in preterm severe intraventricular hemorrhage (IVH).
    J Perinatol 2026.
    


22. Shui JE, LaVita CJ, Alcala GC, Nichols JH, et al.
    Identifying optimal positive end-expiratory pressure with electrical impedance tomography guidance in severe bronchopulmonary dysplasia.
    J Perinatol 2026;46:216-223.
    


23. House M, Lagoski M, DiGeronimo R, Eldredge LC, et al.
    Interdisciplinary clinical bronchopulmonary dysplasia programs: development, evolution, and maturation.
    J Perinatol 2026;46:136-143.
    


24. Munoz-Blanco S, Makker K, McKinney RL, Bamat NA, et al.
    Clinician knowledge, attitudes, and perceptions of delirium in patients with grade 3 bronchopulmonary dysplasia: A national survey.
    J Perinatol 2026;46:206-210.
    


25. Adhikari EH.
    Diagnosis and Management of Syphilis in Pregnancy.
    Obstet Gynecol 2026.
    


26. Heilman EA, Sweeney HE, Stern E, Hoffman MK, et al.
    The Hook & Roll Maneuver for Resolution of Shoulder Dystocia.
    Obstet Gynecol 2026;147:425-429.
    


27. Kilic KM, Ozkan I, Taylan S.
    Global Research Status and Trends in Quality of Life in Children With Cystic Fibrosis From 1985 to 2025: A 40-Year Bibliometric Analysis.
    Pediatr Pulmonol 2026;61:e71524.
    


28. Dagan A, Hadhud M, Efrati O, Cahanovitc SS, et al.
    Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor in Israeli Children Aged 2-6 With Cystic Fibrosis.
    Pediatr Pulmonol 2026;61:e71523.
    


29. G T, H M VS, M A G E B, H M J, et al.
    Linear Growth in Children With Cystic Fibrosis in the Netherlands Born Between 1997-2004; Results of a Multicenter Cohort Analysis.
    Pediatr Pulmonol 2026;61:e71504.
    


30. Tsang KD, Caudri D, Zaat C, Tramper-Stranders GA, et al.
    Peri and Neonatal Risk Factors and Structural Lung Abnormalities Predict Hypoxic Challenge Test Failure in Infants With Severe Bronchopulmonary Dysplasia.
    Pediatr Pulmonol 2026;61:e71517.
    


31. Abi-Aad SJ, Tsalatsanis A, Narkewicz M, Leung DH, et al.
    The Impact of Elexacaftor-Tezacaftor-Ivacaftor on Biochemical Surrogates of Cystic Fibrosis Hepatobiliary Involvement: A Retrospective Cohort Study.
    Pediatr Pulmonol 2026;61:e71522.
    


32. Olgun EG, Mertese SC, Demir AM, Bayav S, et al.
    Thoracic Duct Embolization in a Case of Congenital Chylothorax.
    Pediatr Pulmonol 2026;61:e71516.
    


33. Aoyama BC, Collaco JM, Agarwal A, Akangire G, et al.
    Allergy and atopic phenotype are associated with earlier gestation and severity of respiratory symptoms in bronchopulmonary dysplasia.
    Pediatr Res 2026;99:209-214.
    


34. Yun J, Bae SP, Kim DH, Lee WR, et al.
    Early developmental intervention and neurodevelopmental trajectories in preterm infants without severe brain injury.
    Pediatr Res 2026.
    


35. Torchin H, Dhiman P, Ancel PY, Durrmeyer X, et al.
    Early prediction of bronchopulmonary dysplasia: comparison of modelling methods, development and validation studies.
    Pediatr Res 2026;99:88-95.
    


36. van Wesemael AJ, Klomp K, Malinowska AM, van Kaam AH, et al.
    Early empiric antibiotic exposure affects gut microbiota development of very preterm infants.
    Pediatr Res 2026.
    


37. Bassani G, Decaillet M, Hagmann P, Ledoux JB, et al.
    Blood lactate kinetics as biomarkers of MRI brain injury in neonatal encephalopathy.
    Pediatr Res 2026.
    


38. Neu J, Del Moral T, Guthrie SO, Hudak ML, et al.
    Live biotherapeutic product IBP-9414 (L. reuteri) in very low birth weight infants: the Connection Study.
    Pediatr Res 2026.
    


39. Kastenberg ZJ, Beil CA, Henn L, Alonso EM, et al.
    Demographic Factors and Biliary Atresia: A Childhood Liver Disease Research Network Study.
    Pediatrics 2026.
    


40. Tsung S, Zeng YB, Shah K, Asch SM, et al.
    Cost-Effectiveness of Nirsevimab and Maternal RSVpreF Immunization Strategies in Low-Risk Infants.
    Pediatrics 2026.
    


41. Gainer DJ, Ormiston ML.
    An automated morphometric approach to evaluate distal lung patterning in mouse models of bronchopulmonary dysplasia.
    PLoS One 2026;21:e0333159.
    

 (Display | Copy & Paste | Add to libraries)

Display all articles in

• Abstract format